切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2017, Vol. 14 ›› Issue (04) : 274 -279. doi: 10.3877/cma.j.issn.1672-6448.2017.04.008

所属专题: 文献

浅表器官超声影像学

甲状腺乳头状癌超声造影特征与微血管密度及微血管面积的相关性研究
种静1, 孙咏梅1,(), 宁春平1, 王宏桥1, 杨宗利1, 董海1   
  1. 1. 266003 青岛大学附属医院超声科
  • 收稿日期:2016-11-23 出版日期:2017-04-01
  • 通信作者: 孙咏梅
  • 基金资助:
    国家自然科学基金(81501477)

Contrast-enhanced ultrasound characteristics of papillary thyroid carcinoma and its relationship with microvessel density and microvessel area

Jing Chong1, Yongmei Sun1,(), Chunping Ning1, Hongqiao Wang1, Zongli Yang1, Hai Dong1   

  1. 1. Department of Ultrasound, the Affiliated Hospital of Qingdao University, Qingdao 266003, China
  • Received:2016-11-23 Published:2017-04-01
  • Corresponding author: Yongmei Sun
  • About author:
    Corresponding author: Sun Yongmei, Email:
引用本文:

种静, 孙咏梅, 宁春平, 王宏桥, 杨宗利, 董海. 甲状腺乳头状癌超声造影特征与微血管密度及微血管面积的相关性研究[J/OL]. 中华医学超声杂志(电子版), 2017, 14(04): 274-279.

Jing Chong, Yongmei Sun, Chunping Ning, Hongqiao Wang, Zongli Yang, Hai Dong. Contrast-enhanced ultrasound characteristics of papillary thyroid carcinoma and its relationship with microvessel density and microvessel area[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2017, 14(04): 274-279.

目的

探讨甲状腺乳头状癌(PTC)超声造影血流灌注参数与微血管密度(MVD)及微血管面积(MVA)的相关性,评估超声造影无创性评价PTC血管生成的价值。

方法

选取2014年4月至2016年10月在青岛大学附属医院手术切除并经病理证实的PTC患者69例,按病灶大小将患者分为<1 cm组、1~2 cm组、>2.0 cm组,按颈部淋巴结病理结果将患者分为淋巴结转移组、未转移组。采用t检验(两组间)或单因素方差分析(多组间)比较各组超声造影血流灌注定量参数;对术后结节及甲状腺组织病理标本行免疫组化染色获取MVD及MVA,并与定量参数进行Spearman秩相关性分析。

结果

(1)PTC结节峰值强度(Peak)、曲线下面积(AUC)、MVD及MVA均低于周围正常甲状腺组织(14.95±4.96 vs 22.67±6.11,970.01±263.20 vs 1798.35±563.67,118.91±31.32 vs 206.27±39.58,8.58±2.68 vs 18.47±3.13),差异均有统计学意义(t=-8.700、-11.061、-14.377、-20.532,P均<0.05);(2)随着PTC结节增大,各组Peak及AUC、MVD及MVA依次增加,且不同大小3组结节组间两两比较,差异均有统计学意义(<1 cm组与1~2 cm组比较:t=0.000、0.000、0.000、0.000;<1 cm组与>2.0 cm组比较:t=0.027、0.044、0.033、0.000;1~2 cm组与>2.0 cm比较:t=0.027、0.044、0.033、0.000,P均<0.05);(3)淋巴结转移组Peak、AUC、MVD及MVA值高于未转移组(16.86±4.36 vs 13.80±3.55,1128.16±290.85 vs 874.39±192.27,114.12±30.69 vs 103.67±22.19,10.30±2.44 vs 7.54±2.29),差异均有统计学意义(t=3.177、4.366、6.336、4.742,P均<0.05);(4)相关分析结果显示,Peak、AUC与MVD呈正相关(r=0.506、0.478,P均<0.05),Peak、AUC与MVA呈正相关(r=0.648、0.653,P均<0.05);灌注参数TP、MTT与MVD与MVA无明显相关性。

结论

超声造影定量参数Peak、AUC在一定程度上可反映甲状腺乳头状癌的MVD与MVA,可无创性评价在体肿瘤微血管生成情况,对PTC的临床诊断及其预后的评估具有重要价值。

Objective

To explore the correlation between quantitative parameters of blood perfusion with contrast-enhanced ultrasound (CEUS) and microvessel density (MVD), microvessel area (MVA) in papillary thyroid carcinoma (PTC). And to investigate the value of CEUS in evaluating the angiogenesis in PTC before operation.

Methods

Totally 69 cases of patients with papillary thyroid carcinoma were selected from April 2014 to October 2016 in the Affiliated Hospital of Qingdao University. The CEUS characteristics of 69 patients with papillary thyroid carcinoma confirmed by pathology were retrospectively analyzed. The patients were divided into three groups according to maximum diameter of lesions (<1 cm group, 1-2 cm group and >2.0 cm group), and two groups according to pathologic reports (neck lymph node metastatic and nonmetastatic groups). The blood perfusion parameters between or among different groups were evaluated by ″t″test or one-way ANOVA. Immunohistochemical staining were performed to evaluate the MVD, MVA in the surgical specimens, and the correlation of quantitative parameters with MVD, MVA were assessed by Spearman.

Results

(1) Peak Intensity (Peak), area under the curve (AUC), MVD and MVA of thyroid carcinoma were lower than the surrounding normal thyroid tissue (14.95±4.96 vs 22.67±6.11, 970.01±263.20 vs 1798.35±563.67, 118.91±31.32 vs 206.27±39.58, 8.58±2.68 vs 18.47±3.13), and the differences were statistically significant (t=-8.700, -11.061, -14.377 and -20.532, all P<0.05). (2)With the increase of the lesion′s maximum diameter, Peak, AUC, MVD and MVA increased, and the differences were statistically significant (t=0.000, 0.000, 0.000, 0.000; t=0.027, 0.044, 0.033, 0.000; t=0.027, 0.044, 0.033, 0.000, all P<0.05). (3) Papillary thyroid carcinoma with lymphatic involvement had significantly higher values of Peak, AUC, MVD and MVA than those without lymphatic involvement (16.86±4.36 vs 13.80±3.55, 1128.16±290.85 vs 874.39±192.27, 114.12±30.69 vs 103.67±22.19, 10.30±2.44 vs 7.54±2.29), and the differences were statistically significant (t=3.177, 4.366, 6.336 and 4.742, all P<0.05). (4) A positive correlation existed between the Peak, AUC and MVD, and the differences were statistically significant (r=0.506, 0.478, all P<0.05). Peak, AUC and MVA showed positive correlation, and the differences were statistically significant (r=0.648, 0.653, all P<0.05). TP, MTT and MVD, MVA showed no correlations (all P>0.05).

Conclusions

The values of Peak and AUC calculated from CEUS were correlated to MVD and MVA. CEUS may be used to evaluated the angiogenesis of PTC before operation. And CEUS is helpful for prediction of prognosis of PTC.

表1 PTC患者结节与周围正常组织血流灌注参数及MVD、MVA比较(±s
表2 不同大小PTC患者结节血流灌注参数及MVD、MVA比较(±s
表3 不同淋巴结转移情况的PTC患者结节血流灌注参数及MVD、MVA比较(±s
图1,2 甲状腺乳头状癌患者血流灌注特征。图1为与正常组织相比,甲状腺头状癌病灶增强达峰时呈不均匀性低增强;图2为时间-强度曲线,蓝色代表病灶,绿色代表甲状腺正常组织
图3,4 甲状腺乳头状癌患者CD34免疫组化染色组织病理图(SP ×200)。图3为血管内皮细胞被CD34染成棕色或棕黄色,分布不均匀;图4为Image-Pro Plus 6图像分析软件沿着色的微血管内皮自动半自动勾勒微血管腔,红色表示微血管覆盖区域(SP ×200)。
表4 PTC患者血流灌注参数与MVD、MVA的相关性
[1]
姜珏,张红丽,黄丽丽, 等. 甲状腺腺瘤超声造影特征与病理微血管密度相关性[J]. 中华实用诊断与治疗杂志, 2014, 28(10):983-985.
[2]
董海英,李萍,宁春平, 等. 超声造影定量分析在甲状腺良恶性结节鉴别诊断中的应用价值[J/CD]. 中华医学超声杂志(电子版), 2013, 10(2):110-114.
[3]
Wu Q, Wang Y, Li Y, et al. Diagnostic value of contrast-enhanced ultrasound in solid thyroid nodules with and without enhancement [J]. Endocrine, 2016, 53(2):480-488.
[4]
Xia Y, Jiang YX, Dai Q, et al. Contrast-enhanced ultrasound of hepatocellular carcinoma: Correlation of washout time and angiogenesis [J]. Clin Hemorheol Microcirc, 2011, 48(4):265-273.
[5]
Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis:correlation invasive breast carcinoma [J]. N Engl J Med, 1991, 324(1):1-8.
[6]
周琦,张红丽,黄丽丽, 等. 结节性甲状腺肿超声造影特征与病理微血管密度的相关性[J]. 临床超声医学杂志, 2014, 16(10):661-663.
[7]
Nguyen TB, Cron GO, Bezzina K, et al. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas [J]. AJNR Am J Neuroradiol, 2016, 37(12):2217-2223.
[8]
Lo GM, Al Zahrani H, Jang HJ, et al. Detection of Early Tumor Response to Axitinib in Advanced Hepatocellular Carcinoma by Dynamic Contrast Enhanced Ultrasound [J]. Ultrasound Med Biol, 2016, 42(6):1303-1311.
[9]
梁霞,杨淼,程智, 等. 超声造影对甲状腺单发实性结节良恶性的诊断价值[J]. 临床超声医学杂志, 2014, 16(2):98-100.
[10]
Zhou Q, Jiang J, Shang X, et al. Correlation of Contrast-Enhanced Ultrasonographic Features with Microvessel Density in Papillary Thyroid Carcinomas [J]. Asian Pac J Cancer Prev, 2014, 15(17):7449-7452.
[11]
Tian H, Wang Q. Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound [J]. Eur J Cancer, 2016, 68:82-89.
[12]
Wendl CM, Janke M, Jung W, et al. Contrast-enhanced ultrasound with perfusion analysis for the identification of malignant and benign tumours of the thyroid gland [J]. Clin Hemorheol Microcirc, 2015, 63(2):113-121.
[13]
Bartolotta TV, Midiri M, Galia M, et al. Qualitative and quantitative evaluation of solitary thyroid nodules with contrast-enhanced ultrasound: initial results [J]. Eur Radiol, 2006, 16(10):2234-2241.
[14]
Zhuang PH, Xu L, Gao L, et al. Correlations of microvascular blood flow of contrast-enhanced ultrasound and HGF/c-Met signaling pathway with clinicopathological features and prognosis of patients with hepatocellular carcinoma [J]. Onco Targets Ther, 2017, 10:847-857.
[15]
Zhan WW, Zhou P, Zhou JQ, et al. Differences in sonographic features of papillary thyroid carcinoma between neck lymph node metastatic andnonmetastatic groups [J]. J Ultrasound Med, 2012, 31(6):915-920.
[16]
张波,姜玉新,戴晴, 等. 甲状腺实性结节超声造影与免疫组织化学分析[J]. 中国医学影像技术, 2011, 27(9):1783-1787.
[17]
Yildiz E, Ayan S, Goze F, et al. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma [J]. BJU Int, 2008, 101(6):758-764.
[1] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[2] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[3] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[4] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[5] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[6] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[7] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[8] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[9] 麻紫月, 王贞文, 张强, 赵代伟, 张翊伦. 右侧喉不返神经1例报告[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 115-116.
[10] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[11] 王宇, 徐芳泉, 周旋, 姚晓峰, 李强. 不断提高分化型甲状腺癌根治性切除规范化[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 473-476.
[12] 孙辉, 李长霖. 分化型甲状腺癌根治性切除术中的关键考量与策略[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 477-481.
[13] 高一飞, 刘根祥, 孙长华, 周广军. 喉返神经监测在无充气腋窝入路腔镜单侧甲状腺切除+中央区淋巴结清扫术中的应用效果[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 483-486.
[14] 李云龙, 夏旭良, 江志强, 刘伟, 刘凯, 唐立, 刘昊中, 张思远. 三种方法治疗分化型甲状腺癌的临床疗效[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 487-489.
[15] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
阅读次数
全文


摘要